For instance, the association between MPO-463G > A polymorphism and lung cancer risk has attracted the most attention since the first meta-analysis performed in 2002 and suggested a slight protective effect of the MPO 463 A variant [8]. This evidence concerns the gene MPO and lung carcinoma.